聶德權:將設即日取籌接種新型肺炎疫苗名額 首階段限長者
公務員事務局局長聶德權於電臺節目上表示,對目前的新型肺炎疫苗接種率仍不滿意,他指60歲或以上人口中僅得28%接種首劑疫苗,80歲或以上人口僅得6%。
他指,計劃短期內推出「長者即日籌」,長者可毋須網上預約,直接到接種中心取籌登記資料後接種疫苗。20多間社區疫苗接種中心將每日提供200個即日籌,首階段優先開放予70歲以上長者,稍後再進一步推展至60歲或以上,期望月底前正式推行,將於下週初正式公佈相關細節。
他預計,9月底有機會達70%接種率的羣體免疫屏障,正研究增加預約名額。當局早前要求6萬多名前線政府僱員接種新冠疫苗或定期檢測,目前相關接種率已超過70%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.